{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:56:03Z","timestamp":1761490563924},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rmr.2017.11.009","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T22:47:01Z","timestamp":1525992421000},"page":"452-464","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mucormycoses pulmonaires au cours des traitements de leuc\u00e9mies aigu\u00ebs. Analyse r\u00e9trospective d\u2019une s\u00e9rie de 25\u00a0patients"],"prefix":"10.1016","volume":"35","author":[{"given":"D.","family":"Caillot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Legouge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ferrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.B.","family":"Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Plocque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Estivalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Valot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Abou Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2017.11.009_bib0005","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004\u00a0study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.rmr.2017.11.009_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s15010-013-0539-3","article-title":"SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients","volume":"42","author":"Montagna","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.rmr.2017.11.009_bib0015","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230\u00a0cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005\u00a0and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0025","first-page":"1068","article-title":"Zygomycosis in hematologic malignancies: an emerging fungal infection","volume":"85","author":"Nosari","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.rmr.2017.11.009_bib0030","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.rmr.2017.11.009_bib0040","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/cid\/cir864","article-title":"Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives","volume":"54","author":"Kwon-Chung","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","article-title":"A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response","volume":"59","author":"Ben-Ami","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","article-title":"Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery","volume":"15","author":"Caillot","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2001.tb00010.x","article-title":"Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients","volume":"7","author":"Caillot","year":"2001","journal-title":"Clin Microb Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0060","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3324\/haematol.2013.094359","article-title":"Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome","volume":"98","author":"Nucci","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.rmr.2017.11.009_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0070","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.ejrad.2009.05.058","article-title":"Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials","volume":"74","author":"Caillot","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0075","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0080","first-page":"604","article-title":"Computed tomographic appearance of pulmonary mucormycosis","volume":"172","author":"Vogl","year":"2000","journal-title":"R\u00f6Fo"},{"key":"10.1016\/j.rmr.2017.11.009_bib0085","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/587991","article-title":"Reversed halo sign in invasive pulmonary fungal infections","volume":"46","author":"Wahba","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0090","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0095","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cmi.2015.03.019","article-title":"Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin Microb Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0100","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0105","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhin.2006.10.013","article-title":"Reduced fungal contamination of the indoor environment with the Plasmair\u00ae system (Airinspace)","volume":"65","author":"Sixt","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0115","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/JCM.03500-13","article-title":"Long-term stability at 20\u00b0C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens","volume":"52","author":"Wheat","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2141.1995.tb08355.x","volume":"89","author":"Pagano","year":"1995","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0125","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cmi.2015.12.029","article-title":"Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50\u00a0cases in a single centre","volume":"22","author":"Chretien","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1378\/chest.11-1964","article-title":"Lung resection in hematologic patients with pulmonary invasive fungal disease","volume":"142","author":"Nebiker","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.009_bib0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ejcts\/ezv026","article-title":"Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection","volume":"49","author":"Wu","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.rmr.2017.11.009_bib0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.leukres.2014.01.007","article-title":"Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia","volume":"38","author":"Girmenia","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.rmr.2017.11.009_bib0145","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2017.11.009_bib0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jinf.2012.08.006","article-title":"Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital","volume":"65","author":"Garnaud","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10096-005-1312-z","article-title":"Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections","volume":"24","author":"Petrikkos","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0160","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4187\/respcare.03020","article-title":"Reversed halo sign: a systematic review","volume":"59","author":"Maturu","year":"2014","journal-title":"Resp Care"},{"key":"10.1016\/j.rmr.2017.11.009_bib0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2214\/ajr.180.5.1801251","article-title":"Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications","volume":"180","author":"Kim","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/RTI.0b013e318190476f","article-title":"\u2018Reversed halo sign\u2019 of high-resolution computed tomography in pulmonary sarcoidosis","volume":"24","author":"Kumazoe","year":"2009","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.rmr.2017.11.009_bib0175","first-page":"419","article-title":"A case of psittacosis with wandering infiltrates developing to acute respiratory distress syndrome","volume":"45","author":"Okubo","year":"2007","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.rmr.2017.11.009_bib0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.idc.2009.10.014","article-title":"Legionnaires disease: clinical differentiation from typical and other atypical pneumonias","volume":"24","author":"Cunha","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.rmr.2017.11.009_bib0185","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1259\/bjr\/22699201","article-title":"Pulmonary tuberculosis associated with the reversed halo sign on high-resolution CT","volume":"83","author":"Marchiori","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0190","doi-asserted-by":"crossref","first-page":"20150246","DOI":"10.1259\/bjr.20150246","article-title":"CT morphological features of the reversed halo sign in pulmonary paracoccidioidomycosis","volume":"88","author":"Barreto","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rmr.2017.11.009_bib0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s15010-011-0156-y","article-title":"The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis","volume":"40","author":"Busca","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.rmr.2017.11.009_bib0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0205","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemoter"},{"key":"10.1016\/j.rmr.2017.11.009_bib0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12466","article-title":"Why is mucormycosis more difficult to cure than more common mycoses?","volume":"20","author":"Katragkou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rmr.2017.11.009_bib0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rmr.2017.11.009_bib0225","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91\u00a0cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0230","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/AAC.04035-14","article-title":"Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity","volume":"58","author":"Jung","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rmr.2017.11.009_bib0235","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.009_bib0240","series-title":"Program and abstracts of IDWeek","article-title":"An open-label phase 3\u00a0study of isavuconazole (VITAL): focus on mucormycosis","author":"Marty","year":"2014"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T19:43:47Z","timestamp":1534880627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0761842518300251"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.009","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucormycoses pulmonaires au cours des traitements de leuc\u00e9mies aigu\u00ebs. Analyse r\u00e9trospective d\u2019une s\u00e9rie de 25\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}